Functional pleiotropy of calcium binding protein Regucalcin in signaling and diseases.
Cell Signal
; : 110533, 2022 Nov 25.
Article
in English
| MEDLINE | ID: covidwho-2293865
ABSTRACT
Regucalcin (Mrâ¯~â¯33.38â¯kDa) is a calcium binding protein, discovered in rat liver. In humans, gene for regucalcin is located on chromosome-11 (p11.3-q11.2) consisting of seven exons and six introns. The protein differs from other calcium binding protein in the way that it lacks EF-hand motif of calcium binding domain. It is also called as Senescence Marker Protein-30 (SMP-30) as previously its weight assumes to be 30â¯kDa and expression of this protein decreases with aging in androgen independent manner. Among vertebrates, it is a highly conserved protein showing gene homology in Drosophila, Xenopus, fireflies and others too. It is primarily expressed in liver and kidney in addition to brain, lungs, and skeletal muscles. Regucalcin acts as a Ca2+ regulatory protein and controls various cellular functions in liver and other organs. It suppresses protein phosphatase, protein kinase, DNA and RNA synthesis. Published evidences suggest regucalcin to be a reliable biomarker in various disorders of liver, kidney, brain and ocular. In over expressed state, it subdues apoptosis in cloned rat hepatoma cells and also induces hyperlipidemia and osteoblastogenesis by regulating various factors. Owing to the multi-functionality of regucalcin this review is presented to elaborate its importance in order to understand its involvement in cellular signaling during various pathologies.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Cell Signal
Year:
2022
Document Type:
Article
Affiliation country:
J.cellsig.2022.110533
Similar
MEDLINE
...
LILACS
LIS